Naphazoline Hci 0.027% & Pheniramine Maleate 0.315% Ophthalmic Solution, Usp
5649c6e2-966f-44d9-b57e-5bb988eb373d
34390-5
HUMAN OTC DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
Active Ingredients Naphazoline Hydrochloride (0.027%) Pheniramine Maleate (0.315%)
Medication Information
Warnings and Precautions
Warnings: if you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a physician. Do not use in children under 6 years of age unless directed by a physician. If this solution changes color or becomes cloudy, do not use. Overuse of this product may produce increased redness of the eye.
If you are sensitive to any ingredient in this product, do not use. To avoid contamination, do not touch tip of container to any surface. Replace cap after using.
Indications and Usage
Uses: temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.
Dosage and Administration
Directions:
Adults and children 6 years of age and older: instill 1 or 2 drops in affected eye(s) up to 4 times daily.
Children under 6 years: ask a doctor.
Description
Active Ingredients Naphazoline Hydrochloride (0.027%) Pheniramine Maleate (0.315%)
Section 42229-5
Use before expiration date marked on the carton or bottle.
Available in 15mL NDC 59390-177-13 and 30 mL NDC 59390-177-18
Section 44425-7
Store at room temperature 20 degrees - 25 degrees C ( 68 degrees - 77 degrees F).
Protect from light.
Section 50565-1
Keep out of reach of children.
In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately. Accidental oral ingestion in infants and children may lead to coma and marked reduction in body temperature.
Section 50566-9
Stop use and ask a doctor if you experience: eye pain, changes in vision, redness or irritation of the eye that worsens or persists for more than 72 hours. Overuse of this product may produce increased redness of the eye. Pupils may become enlarged temporarily. You may experience a brief tingling sensation after putting drops in eyes.
Section 50567-7
Remove contact lenses before using.
Section 50569-3
Ask a doctor before use if you have
- heart disease
- high blood pressure
- trouble urinating due to enlarged prostrate gland
- narrow angle glaucoma
Section 50570-1
Do not use if imprinted seal on cap is torn, broken or missing, or if imprinted seals on top ad bottom flaps are not intact and completely legible.
Section 51727-6
Inactive ingredients
benzalkonium chloride 0.01%, boric acid, edetate disodium 0.1%, hypromellose, purified water, sodium borate, and sodium chloride.
Section 51945-4
ALTAIRE Pharmaceuticals, Inc.
Aquebogue, N.Y. 11931
Naphazoline HCI 0.027%
and
Pheniramine Maleate 0.315%
Ophthalmic Solution, USP
Eye Allergy Relief
With Antihistamine To Relieve Itching
Itching and Redness Reliever
Eye Drops
0.5 Fl. OZ. (15mL)
Section 53413-1
Questions or comments
Call (631) 722-5988 9am - 5pm EST Monday - Friday
Section 55105-1
Purpose
Redness Reliever
Antihistamine
Section 55106-9
Active Ingredients
Naphazoline Hydrochloride (0.027%)
Pheniramine Maleate (0.315%)
Structured Label Content
Indications and Usage (34067-9)
Uses: temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.
Dosage and Administration (34068-7)
Directions:
Adults and children 6 years of age and older: instill 1 or 2 drops in affected eye(s) up to 4 times daily.
Children under 6 years: ask a doctor.
Warnings and Precautions (34071-1)
Warnings: if you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a physician. Do not use in children under 6 years of age unless directed by a physician. If this solution changes color or becomes cloudy, do not use. Overuse of this product may produce increased redness of the eye.
If you are sensitive to any ingredient in this product, do not use. To avoid contamination, do not touch tip of container to any surface. Replace cap after using.
Section 42229-5 (42229-5)
Use before expiration date marked on the carton or bottle.
Available in 15mL NDC 59390-177-13 and 30 mL NDC 59390-177-18
Section 44425-7 (44425-7)
Store at room temperature 20 degrees - 25 degrees C ( 68 degrees - 77 degrees F).
Protect from light.
Section 50565-1 (50565-1)
Keep out of reach of children.
In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately. Accidental oral ingestion in infants and children may lead to coma and marked reduction in body temperature.
Section 50566-9 (50566-9)
Stop use and ask a doctor if you experience: eye pain, changes in vision, redness or irritation of the eye that worsens or persists for more than 72 hours. Overuse of this product may produce increased redness of the eye. Pupils may become enlarged temporarily. You may experience a brief tingling sensation after putting drops in eyes.
Section 50567-7 (50567-7)
Remove contact lenses before using.
Section 50569-3 (50569-3)
Ask a doctor before use if you have
- heart disease
- high blood pressure
- trouble urinating due to enlarged prostrate gland
- narrow angle glaucoma
Section 50570-1 (50570-1)
Do not use if imprinted seal on cap is torn, broken or missing, or if imprinted seals on top ad bottom flaps are not intact and completely legible.
Section 51727-6 (51727-6)
Inactive ingredients
benzalkonium chloride 0.01%, boric acid, edetate disodium 0.1%, hypromellose, purified water, sodium borate, and sodium chloride.
Section 51945-4 (51945-4)
ALTAIRE Pharmaceuticals, Inc.
Aquebogue, N.Y. 11931
Naphazoline HCI 0.027%
and
Pheniramine Maleate 0.315%
Ophthalmic Solution, USP
Eye Allergy Relief
With Antihistamine To Relieve Itching
Itching and Redness Reliever
Eye Drops
0.5 Fl. OZ. (15mL)
Section 53413-1 (53413-1)
Questions or comments
Call (631) 722-5988 9am - 5pm EST Monday - Friday
Section 55105-1 (55105-1)
Purpose
Redness Reliever
Antihistamine
Section 55106-9 (55106-9)
Active Ingredients
Naphazoline Hydrochloride (0.027%)
Pheniramine Maleate (0.315%)
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T11:59:12.285202 · Updated: 2026-03-14T22:59:06.604882